PMID: 6121550Apr 1, 1982Paper

Research diagnoses for tardive dyskinesia

Archives of General Psychiatry
N R Schooler, J M Kane

Abstract

No abstract listed.

Citations

Sep 11, 2008·Pharmacogenomics·Bk ThelmaArun Kumar Tiwari
Dec 1, 1998·European Psychiatry : the Journal of the Association of European Psychiatrists·K YoshidaY Hishikawa
Jun 20, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Natascia BrondinoPierluigi Politi
Jun 22, 1999·Biological Psychiatry·G BartzokisJ Mintz
Dec 7, 2006·European Archives of Psychiatry and Clinical Neuroscience·Jose de Leon
Jan 26, 2012·Psychopharmacology·Xiang Yang ZhangThomas R Kosten
Jul 14, 2011·Psychopharmacology·Jeroen P KoningUNKNOWN Genetic Risk and Outcome in Psychosis (GROUP) investigators
Jun 19, 2012·General Hospital Psychiatry·John LallyElizabeth Walsh
Aug 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·A BartonK Ebmeier
Nov 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·J BlinY Agid
Jun 1, 1987·American Journal of Public Health·H MorgensternP Nourjah
Aug 9, 2007·Child and Adolescent Psychiatry and Mental Health·Gahan J PandinaGeorges M Gharabawi
Sep 25, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Iris GrossmanDavid B Goldstein
Oct 2, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Del D MillerUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Nov 11, 2008·Schizophrenia Bulletin·Alexander S YoungKirk McNagny
Jan 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Aoi SyuTadao Arinami
Sep 8, 2010·The Journal of Clinical Psychiatry·Stanley N CaroffUNKNOWN CATIE Investigators
Apr 22, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Margaret G WoernerJohn M Kane
Apr 24, 2013·Journal of Clinical Psychopharmacology·Daniel M BlumbergerBarnett S Meyers
May 30, 2013·BMC Psychiatry·Ray M MerrillPaul M Matiaco
Sep 7, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·B J Havaki-KontaxakiG N Christodoulou
Dec 1, 1996·Italian Journal of Neurological Sciences·M Raja, A Azzoni
Feb 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·P N Van HartenG E Matroos
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·M OmérovN E Larsen
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·J E KalachnikK M Slaw
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Siu-Kau LeungTony Leung
Jun 17, 2003·Journal of the American Medical Directors Association·Richard J Goldberg
Jun 17, 2003·Journal of the American Medical Directors Association·Richard J Goldberg
Jun 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·M CampbellJ E Overall
Feb 25, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·S KumraJ L Rapoport
Feb 12, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Richard P MaloneMary Anne Delaney
Nov 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·D F ConnorK R Ozbayrak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.